Item 5.07 Submission of Matters to a Vote of Security Holders.

eFFECTOR Therapeutics, Inc. (the "Company") held its 2022 Annual Meeting of Stockholders (the "2022 Annual Meeting") on June 9, 2022. The following is a brief description of each matter voted upon at the 2022 Annual Meeting and the number of votes cast for, withheld or against, the number of abstentions and the number of broker non-votes with respect to each matter, as applicable.



    1.   The election of two directors to serve as Class I directors for a
         three-year term to expire at the 2025 Annual Meeting of Stockholders. The
         following two Class I directors were re-elected by the votes indicated:



                               For       Withheld   Broker Non-Votes
Kristen Harrington-Smith    29,225,513    8,999         424,897
Stephen T. Worland, Ph.D.   29,163,847    70,665        424,897



    2.   The ratification of the appointment of Ernst & Young LLP as the Company's
         independent registered public accounting firm for the fiscal year ending
         December 31, 2022. The appointment was ratified by the votes indicated:



   For       Against   Abstain   Broker Non-Votes
29,601,944   54,248     3,217           0

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses